Kidney Cancer Coverage From Every Angle
Advertisement
Advertisement

In the Medical Literature

Post-Progression Response to Nivolumab in Advanced Renal Cell Carcinoma
Adjuvant Pazopanib After Surgery for Locally Advanced Renal Cell Carcinoma
Multigene Panel Testing in Identifying Hereditary Kidney Cancer
Bevacizumab Plus Novel Monoclonal Antibody in Metastatic Kidney Cancer
Sequence of Everolimus and Sunitinib in Metastatic Renal Cell Carcinoma
Can Dynamic Changes During Therapy Predict Survival in Renal Cell Cancer?
Predictive Marker in Nonmetastatic Renal Cell Carcinoma After Nephrectomy
Impact of Margin Status on Survival After Radical Nephrectomy
ALK Inhibitor MK-2206 Versus Everolimus in Refractory Renal Cell Carcinoma
Thyroid Dysfunction in Patients Receiving Immunotherapy for Advanced Kidney Cancer
Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma
Timing of Treatment for Advanced Kidney Cancer
Treatment Outcomes Based on Ethnicity in Metastatic Renal Cell Carcinoma
Combining Nephrectomy and SBRT for Advanced Kidney Cancer
MET Inhibitor Savolitinib in Advanced Papillary Renal Cell Cancer
Pembrolizumab as Second-Line Treatment for Advanced Urothelial Carcinoma
Impact of Everolimus-Induced Pneumonitis on Metastatic Renal Cell Carcinoma
Intermittent Sunitinib in Previously Untreated Metastatic Renal Cell Carcinoma
Vinflunine Maintenance in Advanced Urothelial Carcinoma
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer
Targeted Therapies for Metastatic Chromophobe Renal Cell Carcinoma
Alternating Treatment Regimens in Clear Cell Renal Cell Cancer
Use of Metformin in Patients With Metastatic Renal Cell Carcinoma
Complete Surgical Metastasectomy in Metastatic Renal Cell Carcinoma
Pazopanib vs Paclitaxel in Advanced Urothelial Carcinoma
Potential Biomarker in Metastatic Renal Cell Carcinoma